YS Biopharma Co Ltd
NASDAQ:LSB

Watchlist Manager
YS Biopharma Co Ltd Logo
YS Biopharma Co Ltd
NASDAQ:LSB
Watchlist
Price: 0.627 USD -24.46% Market Closed
Market Cap: 25.8m USD

Wall Street
Price Targets

LSB Price Targets Summary
YS Biopharma Co Ltd

There are no price targets for LSB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
YS Biopharma Co Ltd Competitors:
Price Targets
FOLD
Amicus Therapeutics Inc
14% Upside
9966
Alphamab Oncology
2% Downside
688235
Beigene Ltd
35% Upside
PGEN
Precigen Inc
107% Upside
ALCLS
Cellectis SA
60% Upside
TECX
AVROBIO Inc
274% Upside
PRQR
ProQR Therapeutics NV
350% Upside
CGON
CG Oncology Inc
82% Upside

Revenue
Forecast

Revenue Estimate
YS Biopharma Co Ltd

For the last 2 years the compound annual growth rate for YS Biopharma Co Ltd's revenue is -5%. The projected CAGR for the next 1 year is 128%.

-5%
Past Growth
128%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
YS Biopharma Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
YS Biopharma Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LSB's stock price target?
Not Available

LSB doesn't have any price targets made by Wall Street professionals.

What is YS Biopharma Co Ltd's Revenue forecast?
Projected CAGR
128%

For the last 2 years the compound annual growth rate for YS Biopharma Co Ltd's revenue is -5%. The projected CAGR for the next 1 year is 128%.

Back to Top